• 'Drugs from bugs' joint venture cphi-online
    April 08, 2019
    Lonza and Chr. Hansen create a strategic joint venture to become the partner of choice for developing and manufacturing live biotherapeutic products for pharma and biotech customers.
  • Chr. Hansen gets patent for its probiotic strain in S Korea biospectrumasia
    March 05, 2018
  • Chr. Hansen expands strain library pharmaasia
    June 16, 2017
PharmaSources Customer Service